Fig. 11From: Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patientsTen-group risk stratification chart: (a) for 1-year disease free survival in model group; (b) for 2-year disease free survival in model group; (c) for 3-year disease free survival in model group; (d) for 1-year disease free survival in validation group; (e) for 2-year disease free survival in validation group; (f) for 3-year disease free survival in validation groupBack to article page